Metabolism Applications in Histone Deacetylase Inhibitors

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Pharmacology and Drug Metabolism".

Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 5765

Special Issue Editors


E-Mail Website
Guest Editor
Department of Chemistry and Technology of Drugs, “Sapienza” University of Rome, 00185 Roma, Italy
Interests: drug discovery; epigenetics; medicinal chemistry; chemical biology; radiopharmaceuticals
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Dipartimento di Patologia Generale, Seconda Università degli Studi di Napoli, Vico Luigi de Crecchio 7, 80138 Napoli, Italy
Interests: antitumor activity; epigenetics

Special Issue Information

Dear Colleagues,

Recently, epigenetics research has shed light on the effects of histone acetylation on metabolism, establishing multiple links between histone deacetylases (HDACs), including sirtuins (SIRTs), cell metabolism, and cancer. HDACs play a crucial role in the maintenance of epigenetic transcriptional regulation and seem to be involved in the pathogenesis of various metabolic and age-related disorders, including metabolic syndrome, several inflammatory, cardiovascular, and neurodegenerative conditions, and cancer. Recent insights have just started to outline the therapeutic potential of HDAC inhibitors (HDACi) not only in oncology, but also in the treatment of metabolic diseases. However, the links with energetic metabolism and metabolomics remain under-evaluated aspects in HDAC and HDACi research.

This Special Issue will be dedicated not only to in-depth applications of current metabolomics techniques to functional annotation of HDACs and characterization of HDACi, but also to cutting-edge drug and assay development for potential applications in metabolic conditions. The topics that we aim to cover with this Special Issue include the identification of novel metabolic functions and pathways affected by HDACi treatment, HDAC-related marker discovery for metabolic disease diagnosis and drug development, and metabolomics-driven studies that could help to shed light on the complex metabolic networks related to HDAC activity and inhibition. Manuscripts dealing with these or other challenging issues in the general context of metabolism and HDACs/HDACi will be highly appreciated.

Prof. Dr. Dante Rotili
Prof. Dr. Angela Nebbioso
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epigenetics
  • metabolic diseases
  • histone deacetylase (HDAC) inhibitors
  • metabolomics
  • drug discovery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

16 pages, 1089 KiB  
Review
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
by Jacob King, Maya Patel and Sriram Chandrasekaran
Metabolites 2021, 11(11), 792; https://doi.org/10.3390/metabo11110792 - 20 Nov 2021
Cited by 33 | Viewed by 5116
Abstract
Histone deacetylases (HDACs) are epigenetic enzymes that play a central role in gene regulation and are sensitive to the metabolic state of the cell. The cross talk between metabolism and histone acetylation impacts numerous biological processes including development and immune function. HDAC inhibitors [...] Read more.
Histone deacetylases (HDACs) are epigenetic enzymes that play a central role in gene regulation and are sensitive to the metabolic state of the cell. The cross talk between metabolism and histone acetylation impacts numerous biological processes including development and immune function. HDAC inhibitors are being explored for treating cancers, viral infections, inflammation, neurodegenerative diseases, and metabolic disorders. However, how HDAC inhibitors impact cellular metabolism and how metabolism influences their potency is unclear. Discussed herein are recent applications and future potential of systems biology methods such as high throughput drug screens, cancer cell line profiling, single cell sequencing, proteomics, metabolomics, and computational modeling to uncover the interplay between metabolism, HDACs, and HDAC inhibitors. The synthesis of new systems technologies can ultimately help identify epigenomic and metabolic biomarkers for patient stratification and the design of effective therapeutics. Full article
(This article belongs to the Special Issue Metabolism Applications in Histone Deacetylase Inhibitors)
Show Figures

Graphical abstract

Back to TopTop